Notably, the immunosuppressive molecules CTLA−4 and PD-1 were found to be upregulated in tumor-infiltrating T cells (Figure 3G,H and Supplementary Figure S1), suggesting that while mIL12 reshapes the tumor immune environment and bolsters T cell responses, the upregulation of these molecules may limit therapeutic efficacy. Here, CTLA4 is linked to neoplasm.